随着减重药巨头诺和诺德重磅GLP-1类药物司美格鲁肽在中国的核心分子专利即将于3月到期，一大批中国本土的司美格鲁肽仿制药正在获批路上。据公开信息，目前国内市场上包括九源基因、丽珠集团、华东医药、齐鲁制药、正大天晴在内的十多家本土制药公司的司美格鲁肽仿制药有望在不久的将来上市，还有十余款处于三期临床，一场价格大战即将席卷。一位内分泌专家表示，随着更多仿制药的上市，减重药很快就会迎来“白菜价”时代。（第一财经）
Economics professor Constantin Burgi of University College, Dublin, said a decoupling of job gains and wider growth - like the one the US is seeing today - often occurs when an economy goes through a structural shift, like the advent of AI.，推荐阅读safew官方版本下载获取更多信息
，详情可参考爱思助手下载最新版本
Striker was demoted to under-21s after refusing to play
为应对客流高峰，铁路部门在京广、京沪、沪昆、京哈等主要高铁干线单日安排开行夜间高铁列车超 1000 列，并在热门方向增开临时旅客列车，单日最高增开 2314 列。，详情可参考safew官方版本下载
Reasons that families have given for blocking donations have included not knowing what the patient would have wanted, feeling the process took too long, not wanting any further surgery to the body or being against religious and cultural beliefs.